# DrFirst

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/drfirst

- Industry: Healthcare IT
- Headquarters: Rockville, US
- Website: www.drfirst.com/
- Total disclosed funding: $50M
- Latest round: Series D (May 11, 2021)
- Investors on record: 1

## About

DrFirst, Inc., based in the US, specializes in optimizing healthcare IT solutions that enhance medication management, ensuring safe and efficient patient care across various healthcare settings.Founded in 2000 and headquartered in Rockville, US, DrFirst, Inc. provides innovative healthcare IT solutions aimed at improving medication management. The company has raised a total of USD 50.00 mn through 9 deals, with its most recent funding round being a Series D in May 2021, led by investor Sixth Street. The firm is led by a team comprising CEO Amaia Madina, Chris Cresswell, and Toygun TUNÇER.DrFirst offers a suite of innovative healthcare IT solutions designed to enhance medication management throughout the patient journey. The company's core products include E-Prescribing, Electronic Prescribing for Controlled Substances (EPCS), Electronic Prior Authorization (ePA), medication history, patient engagement tools, and population health management systems. These solutions are integrated into healthcare workflows to streamline processes, reduce prescription errors, and improve patient adherence to treatments. DrFirst serves a diverse client base, including hospitals, health systems, pharmaceutical companies, EHR and HIT vendors, private practices, and payers across the United States. Its products are designed to address critical challenges such as minimizing overprescribing risks, ensuring regulatory compliance, and facilitating seamless transitions of patient data between healthcare systems.DrFirst’s revenue model is primarily based on subscription services and partnerships with various healthcare stakeholders. Clients typically engage with the company through annual subscription agreements for access to its electronic prescribing and medication management solutions. Transactions include direct sales to healthcare providers, which may involve bundled service packages or standalone products tailored to specific needs. The company’s flagship offerings, including Rcopia for electronic prescribing and Backline for secure messaging, form an integral part of its revenue stream as healthcare entities seek to enhance their operational efficiencies and compliance capabilities. Additionally, DrFirst provides value-added services, such as real-time prescription benefit verification and patient engagement tools, contributing to its financial performance through ongoing service utilization.In May 2021, DrFirst.com, Inc. raised USD 50.00 mn in Series D funding, led by returning investor Sixth Street. The funds will be utilized to accelerate the company's growth and create connections to different parts of patient care. The company is focused on expanding its product offerings and exploring new markets, with plans to enhance its solutions and reach additional healthcare providers and organizations in the coming years.

## Funding rounds

- Series D, May 11, 2021, $50M — Sixth Street

## Investors

- Sixth Street (https://capitalatlas.ai/funds/sixth-street) — Series D